Literature DB >> 30297287

Airway Microbiome and Development of Bronchopulmonary Dysplasia in Preterm Infants: A Systematic Review.

Mohan Pammi1, Charitharth Vivek Lal2, Brandie D Wagner3, Peter M Mourani4, Pablo Lohmann5, Ruth Ann Luna6, Amy Sisson7, Binoy Shivanna5, Emily B Hollister6, Steven H Abman8, James Versalovic6, Gary J Connett9, Vineet Bhandari10, Namasivayam Ambalavanan2.   

Abstract

OBJECTIVES: To summarize evidence regarding microbial dysbiosis of the airway associated with bronchopulmonary dysplasia (BPD) and to explore heterogeneity among studies. STUDY
DESIGN: We included studies that evaluated the airway microbiome in preterm infants who developed BPD using culture-independent molecular techniques and reported alpha- and beta-diversity metrics and microbial profiles.
RESULTS: The 6 included studies had substantial clinical and methodological heterogeneity. Most studies reported the presence of an airway microbiome early after birth and an evolution in the first weeks of life with increasing bacterial loads. The early airway microbiome was dominated by Staphylococcus and Ureaplasma spp. Two studies reported differences in alpha- and beta- diversity indices in preterm infants with BPD compared with those who did not develop BPD. Increased microbial community turnover, changes in the relative abundance of Proteobacteria and Firmicutes, and decreased Lactobacilli were reported with BPD progression. Most included infants were born by cesarean delivery, and a majority were exposed to postnatal antibiotics. No data regarding feeding human milk or correlations with the development of gut microbiota (gut-lung axis) were available.
CONCLUSIONS: Microbial dysbiosis may be associated with BPD progression and severity, and further study of microbiome optimization in preterm infants at risk for BPD is warranted.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  airway; bronchopulmonary dysplasia; chronic lung disease; dysbiosis; lung; microbiome; neonate; preterm

Mesh:

Year:  2018        PMID: 30297287     DOI: 10.1016/j.jpeds.2018.08.042

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  18 in total

1.  Mice without a microbiome are partially protected from lung injury by hyperoxia.

Authors:  Kent A Willis; Joseph F Pierre; Stephania A Cormier; Ajay J Talati
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2019-10-30       Impact factor: 5.464

2.  Interactive and independent effects of early lipopolysaccharide and hyperoxia exposure on developing murine lungs.

Authors:  Amrit Kumar Shrestha; Renuka T Menon; Ahmed El-Saie; Roberto Barrios; Corey Reynolds; Binoy Shivanna
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2020-09-09       Impact factor: 5.464

Review 3.  Bronchopulmonary dysplasia.

Authors:  Bernard Thébaud; Kara N Goss; Matthew Laughon; Jeffrey A Whitsett; Steven H Abman; Robin H Steinhorn; Judy L Aschner; Peter G Davis; Sharon A McGrath-Morrow; Roger F Soll; Alan H Jobe
Journal:  Nat Rev Dis Primers       Date:  2019-11-14       Impact factor: 52.329

Review 4.  Bronchopulmonary Dysplasia: Then, Now, and Next.

Authors:  Michael C Tracy; David N Cornfield
Journal:  Pediatr Allergy Immunol Pulmonol       Date:  2020-09       Impact factor: 0.885

Review 5.  Respiratory and Intestinal Microbiota in Pediatric Lung Diseases-Current Evidence of the Gut-Lung Axis.

Authors:  Sebastian Stricker; Torsten Hain; Cho-Ming Chao; Silvia Rudloff
Journal:  Int J Mol Sci       Date:  2022-06-18       Impact factor: 6.208

6.  Intratracheal Transplantation of Mesenchymal Stem Cells Attenuates Hyperoxia-Induced Microbial Dysbiosis in the Lungs, Brain, and Gut in Newborn Rats.

Authors:  So Yoon Ahn; Dong Kyung Sung; Yun Sil Chang; Won Soon Park
Journal:  Int J Mol Sci       Date:  2022-06-13       Impact factor: 6.208

Review 7.  The Role of Lung and Gut Microbiota in the Pathology of Asthma.

Authors:  Weronika Barcik; Rozlyn C T Boutin; Milena Sokolowska; B Brett Finlay
Journal:  Immunity       Date:  2020-02-18       Impact factor: 31.745

Review 8.  Bronchopulmonary dysplasia: what are its links to COPD?

Authors:  Sharon A McGrath-Morrow; Joseph M Collaco
Journal:  Ther Adv Respir Dis       Date:  2019 Jan-Dec       Impact factor: 4.031

9.  Dissimilarity of the gut-lung axis and dysbiosis of the lower airways in ventilated preterm infants.

Authors:  David Gallacher; Emma Mitchell; Dagmar Alber; Richard Wach; Nigel Klein; Julian R Marchesi; Sailesh Kotecha
Journal:  Eur Respir J       Date:  2020-05-07       Impact factor: 16.671

Review 10.  Perspectives on Probiotics and Bronchopulmonary Dysplasia.

Authors:  Kun Yang; Wenbin Dong
Journal:  Front Pediatr       Date:  2020-10-23       Impact factor: 3.418

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.